Development of Novel Drug Delivery Systems for Targeted Cancer Therapy

Thesis Overview

The project titled "Development of Novel Drug Delivery Systems for Targeted Cancer Therapy" aims to explore innovative approaches to enhance the effectiveness and precision of cancer treatment. Cancer remains a significant global health challenge, necessitating the development of advanced therapeutic strategies to improve patient outcomes. Traditional cancer treatments such as chemotherapy often lack specificity, leading to systemic toxicity and adverse side effects. Targeted drug delivery systems offer a promising solution by delivering therapeutic agents directly to cancer cells while minimizing damage to healthy tissues. This research project will focus on the design, development, and evaluation of novel drug delivery systems tailored for targeted cancer therapy. The study will involve the synthesis of biocompatible materials and the incorporation of anticancer drugs to formulate specialized drug delivery vehicles. These drug delivery systems will be engineered to actively target cancer cells through specific ligand-receptor interactions or passive accumulation in tumor tissues via the enhanced permeability and retention effect. The project will include comprehensive in vitro and in vivo studies to assess the efficacy and safety of the developed drug delivery systems. Various characterization techniques, including physicochemical analysis, drug release kinetics, cellular uptake studies, and cytotoxicity assays, will be employed to evaluate the performance of the drug delivery vehicles. Animal studies will further investigate the pharmacokinetics, biodistribution, and therapeutic efficacy of the formulated systems in relevant cancer models. Moreover, the research will explore the potential of combining targeted drug delivery systems with other treatment modalities such as immunotherapy or photodynamic therapy to achieve synergistic therapeutic effects. The integration of advanced technologies, such as nanomedicine and personalized medicine approaches, will be considered to tailor the treatment to individual patient characteristics and tumor profiles. Overall, this project seeks to contribute to the advancement of cancer therapy by developing tailored drug delivery systems that enhance treatment efficacy, reduce side effects, and improve patient quality of life. The outcomes of this research have the potential to significantly impact the field of oncology and pave the way for the translation of innovative drug delivery technologies into clinical practice, ultimately benefiting cancer patients worldwide.